Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictive Role of C-reactive Protein to Albumin Ratio (CAR) in the Treatment of Septic Arthritis in Young Chlidren

NCT06241365 is registered in ClinicalTrials.gov with wangxiaodong as lead sponsor.

NCT NCT06241365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06241365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictive Role of C-reactive Protein to Albumin Ratio (CAR) in the Treatment of Septic Arthritis in Young Chlidren
Lead sponsor
wangxiaodong
Phase
Observational
Overall status
Completed
Start date
January 5, 2016
Completion date
December 1, 2023
Enrollment
82 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

septic arthritis